Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects
暂无分享,去创建一个
A. Vliet | D. Cutler | T. Kosoglou | A. V. van Vliet | Bo Yang | L. Reyderman | R. Keller | R. Tiessen | R. R. Fales | D. Cutler | Bo Yang